Pharma Journalist -

Mallinckrodt plc announced that the U.S. Food and Drug Administration (FDA) approved Terlivaz (terlipressin) for injection. Terlivaz is the first and only FDA-approved product indicated…
Read More...

Oxford Biomedica plc announces that its subsidiary Oxford Biomedica Solutions LLC has signed an agreement with a new undisclosed, U.S. based, private biotechnology company. The…
Read More...

BriaCell Therapeutics Corp. announces that it has signed an agreement with Caris Life Sciences (Caris). “Our goal is to develop immunotherapies that are personalized for each patient,…
Read More...

The U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND) – a…
Read More...

Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, announced the close of a $43.5 million Series B financing. The…
Read More...

Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII) announced that the South African Health Products Regulatory Authority has granted full product registration with conditions…
Read More...

Valeo and the French Alternative Energies and Atomic Energy Commission (CEA) signed an agreement to collaborate on the next generations of power electronics, which are at the heart of…
Read More...

Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, and…
Read More...

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced a $160 million Series D financing co-led by…
Read More...

Syros Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SY-5609 for the treatment of pancreatic cancer.…
Read More...